Stock IOLCP IOL CHEMICALS AND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials IOL Chemicals and Pharmaceuticals Limited

Equities

IOLCP

INE485C01011

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 04:49:23 14/05/2024 BST 		5-day change 1st Jan Change
380 INR +1.70% Intraday chart for IOL Chemicals and Pharmaceuticals Limited -3.38% -19.35%
03-19 IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT
02-19 IOL Chemicals Gets Nod to Export Diabetes Drug to China MT

Valuation

Fiscal Period: März 2023 2024 2025 2026
Capitalization 1 16,608 21,932 - -
Enterprise Value (EV) 1 16,608 21,932 21,932 21,932
P/E ratio 11.9 x 11.8 x 9.41 x 8.8 x
Yield 1.41% 1.7% 1.9% 2.06%
Capitalization / Revenue 0.75 x 0.92 x 0.82 x 0.77 x
EV / Revenue 0.75 x 0.92 x 0.82 x 0.77 x
EV / EBITDA 7.36 x 7.29 x 5.86 x 5.46 x
EV / FCF -18.5 x 13.6 x 258 x 22.5 x
FCF Yield -5.39% 7.34% 0.39% 4.44%
Price to Book 1.1 x 1.32 x 1.19 x 1.07 x
Nbr of stocks (in thousands) 58,706 58,706 - -
Reference price 2 282.9 373.6 373.6 373.6
Announcement Date 28/04/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2023 2024 2025 2026
Net sales 1 22,171 23,960 26,650 28,405
EBITDA 1 2,257 3,010 3,743 4,020
EBIT 1 2,051 2,540 3,164 3,380
Operating Margin 9.25% 10.6% 11.87% 11.9%
Earnings before Tax (EBT) 1 1,886 2,529 3,152 3,367
Net income 1 1,391 1,857 2,331 2,490
Net margin 6.28% 7.75% 8.75% 8.77%
EPS 2 23.70 31.60 39.70 42.45
Free Cash Flow 1 -895.5 1,610 85 973
FCF margin -4.04% 6.72% 0.32% 3.43%
FCF Conversion (EBITDA) - 53.49% 2.27% 24.2%
FCF Conversion (Net income) - 86.7% 3.65% 39.07%
Dividend per Share 2 4.000 6.350 7.100 7.700
Announcement Date 28/04/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: März 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 5,414 5,235 5,872 5,632 5,982 6,002 6,319
EBITDA 1 - 426.9 953 725.2 849.5 770 778
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income 1 - 237.9 647.8 458.6 547 484 494
Net margin - 4.54% 11.03% 8.14% 9.14% 8.06% 7.82%
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 14/11/22 07/02/23 28/04/23 09/08/23 - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: März 2023 2024 2025 2026
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -896 1,610 85 973
ROE (net income / shareholders' equity) 9.6% 11.8% 13.3% 12.8%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 257.0 282.0 315.0 349.0
Cash Flow per Share - - - -
Capex 1 2,118 2,000 1,975 1,975
Capex / Sales 9.55% 8.35% 7.41% 6.95%
Announcement Date 28/04/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for IOL Chemicals and Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
373.6 INR
Average target price
517 INR
Spread / Average Target
+38.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IOL CHEMICALS AND PHARMACEUTICALS LIMITED Stock IOL Chemicals and Pharmaceuticals Limited
-19.35% 268M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.98% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.34% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.52% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.59% 329B
ABBVIE INC. Stock AbbVie Inc.
+4.07% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.21% 240B
NOVARTIS AG Stock Novartis AG
+9.66% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-6.83% 200B
AMGEN INC. Stock Amgen Inc.
+7.09% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IOLCP Stock
  4. Financials IOL Chemicals and Pharmaceuticals Limited